<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01064050</url>
  </required_header>
  <id_info>
    <org_study_id>0708042</org_study_id>
    <secondary_id>2007-A01190-53</secondary_id>
    <nct_id>NCT01064050</nct_id>
  </id_info>
  <brief_title>Role of a Silicone Prosthesis to Prevent Airway Obstruction Recurrence in Lung Cancers</brief_title>
  <acronym>SPOC</acronym>
  <official_title>Role of a Silicone Prosthesis to Prevent Airway Obstruction Recurrence After Therapeutic Bronchoscopy in Lung Cancers (SPOC Study)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier Universitaire de Saint Etienne</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Ministry of Health, France</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Ligue contre le cancer, France</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Centre Hospitalier Universitaire de Saint Etienne</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      A tumoral obstruction of the main stem bronchus is frequently observed in the follow-up of
      lung cancers with a high impact on survival and quality of life of these patients. The
      endoluminal resection of these tumors through interventional bronchoscopy can remove the
      tumor but fails to prevent the recurrence. A stent insertion could achieve this goal but this
      option was never proved in a prospective protocol.

      The aim of this study is to analyze the impact of stent insertion on the survival without
      symptoms of bronchial obstruction in patients treated for their cancer with and without a
      first line treatment (chemo-radiotherapy or chemotherapy). The patients will be included
      after resection of the endoluminal symptomatic tumoral obstruction. We will test the effect
      of the silicone stent insertion ( from NovatechR ) by comparing a stent arm (170 patients
      with stent insertion) with a control arm (170 patients without stent). The inclusion period
      will last 3 years with one year of follow-up for each patient. The one-year survival without
      symptomatic recurrence (proved on bronchoscopy with more than 50% of obstruction in the
      treated zone) will be the main endpoint. All patients without symptomatic recurrence at one
      year will be controlled endoscopically. Survival and stent tolerance will be studied as
      secondary endpoints. All endoscopic events will be depicted on photographs or videos. Each
      endoscopical situation (before and after resection, recurrence or side effects of stents)
      will be analyzed and registered by an independent committee of 3 international experts.
    </textblock>
  </brief_summary>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    Difficulty to include patient
  </why_stopped>
  <start_date>November 2008</start_date>
  <completion_date type="Actual">May 2012</completion_date>
  <primary_completion_date type="Actual">May 2012</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Death and / or symptomatic recurrence (proved on bronchoscopy with more than 50% of obstruction in the treated zone)</measure>
    <time_frame>12 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>death</measure>
    <time_frame>12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>For patients who had no symptomatic recurrence of bronchial obstruction Presence of a bronchial stenosis&gt; 50% on a systematic bronchial endoscopy months.</measure>
    <time_frame>12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Complications of symptomatic trachea-bronchial prosthesis (mobility or migration, granuloma, congestion) motivating endoscopy.</measure>
    <time_frame>12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of life : EORTC</measure>
    <time_frame>12 months</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">75</enrollment>
  <condition>Lung Neoplasm</condition>
  <condition>Carcinoma, Non-Small-Cell Lung</condition>
  <arm_group>
    <arm_group_label>trachea-bronchial stent (Novatech)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>control</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>silicone trachea-bronchial stent Dumon (Novatech)</intervention_name>
    <description>Bronchial desobstruction under interventional bronchoscopy, for inclusion, with the insertion of silicone stent trachea-bronchial covering the entire tumor area</description>
    <arm_group_label>trachea-bronchial stent (Novatech)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  &gt; 18 years

          -  non-small cell lung cancer,

          -  inoperable and location : tracheal, carinal, main bronchus right or left, or
             intermediate trunk.

          -  TNM stage known and oncological treatment later determined

          -  central initial intrinsic bronchial obstruction &gt; 50%.

          -  resection of tumor with endoscopy, to obtain after therapeutic bronchoscopy a diameter
             &gt; 50% normal diameter of bronchial segment achieved.

          -  Tumoral segment fully recoverable by a stent

          -  Written consent, free and informed

          -  Patient affiliated or who is entitled to to a social security scheme.

        Exclusion Criteria:

          -  against-indication for general anesthesia.

          -  Patient with one lung not working beyond the stenosis

          -  Patient under guardianship

          -  Pregnancy

          -  12 months follow-up impossible
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jean-Michel Vergnon, MD PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>CHU SAINT-ETIENNE</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Department of pneumology, CHU Amiens</name>
      <address>
        <city>Amiens</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Departement of pneumology, CHU Brest</name>
      <address>
        <city>Brest</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Pneumology departement, HÃ´pital Percy</name>
      <address>
        <city>Clamart</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Pneumology departement, CHRU Lille</name>
      <address>
        <city>Lille</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Pneumology departement, CHU Limoges</name>
      <address>
        <city>Limoges</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Pneumology departement, Sainte Marguerite hospital</name>
      <address>
        <city>Marseille</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Pneumology departement, CHU Nantes</name>
      <address>
        <city>Nantes</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Pneumology departement, Saint-Antoine hospital</name>
      <address>
        <city>Paris</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Department of respiratory diseases and allergic, Thoracic Oncology, CHU Reims</name>
      <address>
        <city>Reims</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Pneumology Clinic - Albert Calmette hospital- CHU Rouen</name>
      <address>
        <city>Rouen</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Pneumology departement CHU Saint-Etienne</name>
      <address>
        <city>Saint-etienne</city>
        <zip>42055</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Endoscopy unit, Thoracic surgery department, Foch Hospital</name>
      <address>
        <city>Suresnes</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Departement of pneumology, CHU TOULOUSE</name>
      <address>
        <city>Toulouse</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>July 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 2, 2010</study_first_submitted>
  <study_first_submitted_qc>February 5, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 8, 2010</study_first_posted>
  <last_update_submitted>July 27, 2015</last_update_submitted>
  <last_update_submitted_qc>July 27, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 28, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>tumoral obstruction of the main stem bronchus</keyword>
  <keyword>bronchoscopy</keyword>
  <keyword>silicone stent</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Recurrence</mesh_term>
    <mesh_term>Carcinoma, Non-Small-Cell Lung</mesh_term>
    <mesh_term>Lung Neoplasms</mesh_term>
    <mesh_term>Airway Obstruction</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

